DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Viral kinetic modeling: state of the art

Abstract

Viral kinetic modeling has led to increased understanding of the within host dynamics of viral infections and the effects of therapy. Here we review recent developments in the modeling of viral infection kinetics with emphasis on two infectious diseases: hepatitis C and influenza. We review how viral kinetic modeling has evolved from simple models of viral infections treated with a drug or drug cocktail with an assumed constant effectiveness to models that incorporate drug pharmacokinetics and pharmacodynamics, as well as phenomenological models that simply assume drugs have time varying-effectiveness. We also discuss multiscale models that include intracellular events in viral replication, models of drug-resistance, models that include innate and adaptive immune responses and models that incorporate cell-to-cell spread of infection. Overall, viral kinetic modeling has provided new insights into the understanding of the disease progression and the modes of action of several drugs. In conclusion, we expect that viral kinetic modeling will be increasingly used in the coming years to optimize drug regimens in order to improve therapeutic outcomes and treatment tolerability for infectious diseases.

Authors:
 [1];  [1]
  1. Los Alamos National Lab. (LANL), Los Alamos, NM (United States). Theoretical Biology and Biophysics
Publication Date:
Research Org.:
Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
Sponsoring Org.:
USDOE; National Institutes of Health (NIH)
OSTI Identifier:
1282052
Grant/Contract Number:  
AC52-06NA25396; R01-AI028433; P20-GM10345; R01-AI078881; R34-HL109334; R01-OD011095
Resource Type:
Accepted Manuscript
Journal Name:
Journal of Pharmacokinetics and Pharmacodynamics
Additional Journal Information:
Journal Volume: 41; Journal Issue: 5; Journal ID: ISSN 1567-567X
Publisher:
Springer
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES; 97 MATHEMATICS AND COMPUTING; Viral kinetics; Hepatitis C; Influenza; Mathematical modeling; Antiviral drug; Resistance emergence

Citation Formats

Canini, Laetitia, and Perelson, Alan S. Viral kinetic modeling: state of the art. United States: N. p., 2014. Web. doi:10.1007/s10928-014-9363-3.
Canini, Laetitia, & Perelson, Alan S. Viral kinetic modeling: state of the art. United States. https://doi.org/10.1007/s10928-014-9363-3
Canini, Laetitia, and Perelson, Alan S. Wed . "Viral kinetic modeling: state of the art". United States. https://doi.org/10.1007/s10928-014-9363-3. https://www.osti.gov/servlets/purl/1282052.
@article{osti_1282052,
title = {Viral kinetic modeling: state of the art},
author = {Canini, Laetitia and Perelson, Alan S.},
abstractNote = {Viral kinetic modeling has led to increased understanding of the within host dynamics of viral infections and the effects of therapy. Here we review recent developments in the modeling of viral infection kinetics with emphasis on two infectious diseases: hepatitis C and influenza. We review how viral kinetic modeling has evolved from simple models of viral infections treated with a drug or drug cocktail with an assumed constant effectiveness to models that incorporate drug pharmacokinetics and pharmacodynamics, as well as phenomenological models that simply assume drugs have time varying-effectiveness. We also discuss multiscale models that include intracellular events in viral replication, models of drug-resistance, models that include innate and adaptive immune responses and models that incorporate cell-to-cell spread of infection. Overall, viral kinetic modeling has provided new insights into the understanding of the disease progression and the modes of action of several drugs. In conclusion, we expect that viral kinetic modeling will be increasingly used in the coming years to optimize drug regimens in order to improve therapeutic outcomes and treatment tolerability for infectious diseases.},
doi = {10.1007/s10928-014-9363-3},
journal = {Journal of Pharmacokinetics and Pharmacodynamics},
number = 5,
volume = 41,
place = {United States},
year = {Wed Jun 25 00:00:00 EDT 2014},
month = {Wed Jun 25 00:00:00 EDT 2014}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 58 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Effects of Aging on Influenza Virus Infection Dynamics
journal, January 2014

  • Hernandez-Vargas, E. A.; Wilk, E.; Canini, L.
  • Journal of Virology, Vol. 88, Issue 8
  • DOI: 10.1128/JVI.03644-13

Effect of 1918 PB1-F2 Expression on Influenza A Virus Infection Kinetics
journal, February 2011


A Viral Dynamic Model for Treatment Regimens with Direct-acting Antivirals for Chronic Hepatitis C Infection
journal, January 2012


Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
journal, January 1995

  • Ho, David D.; Neumann, Avidan U.; Perelson, Alan S.
  • Nature, Vol. 373, Issue 6510
  • DOI: 10.1038/373123a0

Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense.
journal, February 1998

  • Hayden, F. G.; Fritz, R.; Lobo, M. C.
  • Journal of Clinical Investigation, Vol. 101, Issue 3
  • DOI: 10.1172/JCI1355

Differential decay kinetics of human cytomegalovirus glycoprotein B genotypes following antiviral chemotherapy
journal, May 2012

  • Emery, Vincent C.; Manuel, Oriol; Asberg, Anders
  • Journal of Clinical Virology, Vol. 54, Issue 1
  • DOI: 10.1016/j.jcv.2012.01.015

Decay characteristics of HIV-1-infected compartments during combination therapy
journal, May 1997

  • Perelson, Alan S.; Essunger, Paulina; Cao, Yunzhen
  • Nature, Vol. 387, Issue 6629
  • DOI: 10.1038/387188a0

Multiscale Modeling of Influenza A Virus Infection Supports the Development of Direct-Acting Antivirals
journal, November 2013


Influenza virus aerosol exposure and analytical system for ferrets
journal, May 2011

  • Gustin, K. M.; Belser, J. A.; Wadford, D. A.
  • Proceedings of the National Academy of Sciences, Vol. 108, Issue 20
  • DOI: 10.1073/pnas.1100768108

Prediction of cytomegalovirus load and resistance patterns after antiviral chemotherapy
journal, June 2000

  • Emery, V. C.; Griffiths, P. D.
  • Proceedings of the National Academy of Sciences, Vol. 97, Issue 14
  • DOI: 10.1073/pnas.140123497

Inferring Viral Dynamics in Chronically HCV Infected Patients from the Spatial Distribution of Infected Hepatocytes
journal, November 2014


Hepatitis B Virus Kinetics under Antiviral Therapy Sheds Light on Differences in Hepatitis B e Antigen Positive and Negative Infections
journal, November 2010

  • Ribeiro, Ruy M.; Germanidis, Georgios; Powers, Kimberly A.
  • The Journal of Infectious Diseases, Vol. 202, Issue 9
  • DOI: 10.1086/656528

Hepatitis C Viral Kinetics in the Era of Direct Acting Antiviral Agents and Interleukin-28B
journal, July 2011

  • Dahari, Harel; Guedj, Jeremie; Perelson, Alan S.
  • Current Hepatitis Reports, Vol. 10, Issue 3
  • DOI: 10.1007/s11901-011-0101-7

Pharmacodynamics of PEG-IFN-α-2a in HIV/HCV co-infected patients: Implications for treatment outcomes
journal, September 2010

  • Dahari, Harel; Affonso de Araujo, Evaldo S.; Haagmans, Bart L.
  • Journal of Hepatology, Vol. 53, Issue 3
  • DOI: 10.1016/j.jhep.2010.03.019

Towards a quantitative understanding of the within-host dynamics of influenza A infections
journal, March 2009

  • Handel, Andreas; Longini, Ira M.; Antia, Rustom
  • Journal of The Royal Society Interface, Vol. 7, Issue 42
  • DOI: 10.1098/rsif.2009.0067

Dynamics of hepatitis B virus clearance in chimpanzees
journal, November 2005

  • Murray, J. M.; Wieland, S. F.; Purcell, R. H.
  • Proceedings of the National Academy of Sciences, Vol. 102, Issue 49
  • DOI: 10.1073/pnas.0508913102

Modeling amantadine treatment of influenza A virus in vitro
journal, September 2008

  • Beauchemin, Catherine A. A.; McSharry, James J.; Drusano, George L.
  • Journal of Theoretical Biology, Vol. 254, Issue 2
  • DOI: 10.1016/j.jtbi.2008.05.031

Quantifying HTLV‐I dynamics
journal, March 2007

  • Asquith, Becca; Bangham, Charles R. M.
  • Immunology & Cell Biology, Vol. 85, Issue 4
  • DOI: 10.1038/sj.icb.7100050

A Hepatitis C Virus Infection Model with Time-Varying Drug Effectiveness: Solution and Analysis
journal, August 2014


FluTE, a Publicly Available Stochastic Influenza Epidemic Simulation Model
journal, January 2010

  • Chao, Dennis L.; Halloran, M. Elizabeth; Obenchain, Valerie J.
  • PLoS Computational Biology, Vol. 6, Issue 1
  • DOI: 10.1371/journal.pcbi.1000656

Analysis of Hepatitis C Virus Decline during Treatment with the Protease Inhibitor Danoprevir Using a Multiscale Model
journal, March 2013


An in-host model of acute infection: Measles as a case study
journal, February 2008


Dynamics of Influenza Virus Infection and Pathology
journal, February 2010

  • Saenz, R. A.; Quinlivan, M.; Elton, D.
  • Journal of Virology, Vol. 84, Issue 8
  • DOI: 10.1128/JVI.02078-09

Kinetics of Coinfection with Influenza A Virus and Streptococcus pneumoniae
journal, March 2013


Mathematical analysis of multiscale models for hepatitis C virus dynamics under therapy with direct-acting antiviral agents
journal, September 2013


A dynamical model of human immune response to influenza A virus infection
journal, May 2007

  • Hancioglu, Baris; Swigon, David; Clermont, Gilles
  • Journal of Theoretical Biology, Vol. 246, Issue 1
  • DOI: 10.1016/j.jtbi.2006.12.015

Kinetics of Influenza A Virus Infection in Humans
journal, July 2006

  • Baccam, P.; Beauchemin, C.; Macken, C. A.
  • Journal of Virology, Vol. 80, Issue 15
  • DOI: 10.1128/JVI.01623-05

Quantifying the Early Immune Response and Adaptive Immune Response Kinetics in Mice Infected with Influenza A Virus
journal, April 2010

  • Miao, H.; Hollenbaugh, J. A.; Zand, M. S.
  • Journal of Virology, Vol. 84, Issue 13
  • DOI: 10.1128/JVI.00266-10

Influenza A virus infection kinetics: quantitative data and models: Modeling influenza kinetics
journal, December 2010

  • Smith, Amber M.; Perelson, Alan S.
  • Wiley Interdisciplinary Reviews: Systems Biology and Medicine, Vol. 3, Issue 4
  • DOI: 10.1002/wsbm.129

Strategies for containing an emerging influenza pandemic in Southeast Asia
journal, August 2005

  • Ferguson, Neil M.; Cummings, Derek A. T.; Cauchemez, Simon
  • Nature, Vol. 437, Issue 7056
  • DOI: 10.1038/nature04017

Differential lung NK cell responses in avian influenza virus infected chickens correlate with pathogenicity
journal, August 2013

  • Jansen, Christine A.; de Geus, Eveline D.; van Haarlem, Daphne A.
  • Scientific Reports, Vol. 3, Issue 1
  • DOI: 10.1038/srep02478

Combination Antiviral Therapy for Influenza: Predictions From Modeling of Human Infections
journal, March 2012

  • Perelson, Alan S.; Rong, Libin; Hayden, Frederick G.
  • The Journal of Infectious Diseases, Vol. 205, Issue 11
  • DOI: 10.1093/infdis/jis265

Rapid localized spread and immunologic containment define Herpes simplex virus-2 reactivation in the human genital tract
journal, April 2013


Viral dynamics in hepatitis B virus infection.
journal, April 1996

  • Nowak, M. A.; Bonhoeffer, S.; Hill, A. M.
  • Proceedings of the National Academy of Sciences, Vol. 93, Issue 9
  • DOI: 10.1073/pnas.93.9.4398

Modelling the kinetics of hepatitis C virus RNA decline over 4 weeks of treatment with pegylated interferon α-2b
journal, May 2008


A Comprehensive Hepatitis C Viral Kinetic Model Explaining Cure
journal, May 2010

  • Snoeck, E.; Chanu, P.; Lavielle, M.
  • Clinical Pharmacology & Therapeutics, Vol. 87, Issue 6
  • DOI: 10.1038/clpt.2010.35

Differences in Viral Dynamics between Genotypes 1 and 2 of Hepatitis C Virus
journal, July 2000

  • Neumann, Avidan U.; Lam, Nancy P.; Dahari, Harel
  • The Journal of Infectious Diseases, Vol. 182, Issue 1
  • DOI: 10.1086/315661

Towards multiscale modeling of influenza infection
journal, September 2013

  • Murillo, Lisa N.; Murillo, Michael S.; Perelson, Alan S.
  • Journal of Theoretical Biology, Vol. 332
  • DOI: 10.1016/j.jtbi.2013.03.024

Modeling hepatitis C virus dynamics: Liver regeneration and critical drug efficacy
journal, July 2007


Simultaneous detection of hepatitis C virus and interferon stimulated gene expression in infected human liver
journal, April 2014

  • Wieland, Stefan; Makowska, Zuzanna; Campana, Benedetta
  • Hepatology, Vol. 59, Issue 6
  • DOI: 10.1002/hep.26770

Modelling cytomegalovirus replication patterns in the human host: factors important for pathogenesis
journal, April 2006

  • Regoes, Roland R.; Frances Bowen, E.; Cope, Alethea V.
  • Proceedings of the Royal Society B: Biological Sciences, Vol. 273, Issue 1596
  • DOI: 10.1098/rspb.2006.3506

The role of cells refractory to productive infection in acute hepatitis B viral dynamics
journal, March 2007

  • Ciupe, S. M.; Ribeiro, R. M.; Nelson, P. W.
  • Proceedings of the National Academy of Sciences, Vol. 104, Issue 12
  • DOI: 10.1073/pnas.0603626104

Rapid Emergence of Protease Inhibitor Resistance in Hepatitis C Virus
journal, May 2010


IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C
journal, November 2011


Triphasic decline of hepatitis C virus RNA during antiviral therapy
journal, January 2007

  • Dahari, Harel; Ribeiro, Ruy M.; Perelson, Alan S.
  • Hepatology, Vol. 46, Issue 1
  • DOI: 10.1002/hep.21657

HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time
journal, March 1996


Dynamics of hepatitis B virus infection
journal, July 2002


Spatial Aspects of HIV Infection
book, September 2012


Pharmacodynamics of PEG-IFN α differentiate HIV/HCV coinfected sustained virological responders from nonresponders
journal, May 2006

  • Talal, Andrew H.; Ribeiro, Ruy M.; Powers, Kimberly A.
  • Hepatology, Vol. 43, Issue 5
  • DOI: 10.1002/hep.21136

Understanding silibinin’s modes of action against HCV using viral kinetic modeling
journal, May 2012


Transmissibility of 1918 pandemic influenza
journal, December 2004

  • Mills, Christina E.; Robins, James M.; Lipsitch, Marc
  • Nature, Vol. 432, Issue 7019
  • DOI: 10.1038/nature03063

Modeling complex decay profiles of hepatitis B virus during antiviral therapy
journal, August 2008

  • Dahari, Harel; Shudo, Emi; Ribeiro, Ruy M.
  • Hepatology, Vol. 49, Issue 1
  • DOI: 10.1002/hep.22586

A Multi-Variant, Viral Dynamic Model of Genotype 1 HCV to Assess the in vivo Evolution of Protease-Inhibitor Resistant Variants
journal, April 2010


Understanding the symptoms of the common cold and influenza
journal, November 2005


Directly transmitted infections diseases: control by vaccination
journal, February 1982


Impact of Different Oseltamivir Regimens on Treating Influenza A Virus Infection and Resistance Emergence: Insights from a Modelling Study
journal, April 2014


Understanding the Dose-Effect Relationship: Clinical Application of Pharmacokinetic-Pharmacodynamic Models
journal, January 1981


Modelling viral and immune system dynamics
journal, January 2002

  • Perelson, Alan S.
  • Nature Reviews Immunology, Vol. 2, Issue 1
  • DOI: 10.1038/nri700

The Kinetics of Mucosal Herpes Simplex Virus–2 Infection in Humans: Evidence for Rapid Viral-Host Interactions
journal, August 2011

  • Schiffer, Joshua T.; Wald, Anna; Selke, Stacy
  • The Journal of Infectious Diseases, Vol. 204, Issue 4
  • DOI: 10.1093/infdis/jir314

Modeling HCV kinetics under therapy using PK and PD information
journal, March 2009

  • Shudo, Emi; Ribeiro, Ruy M.; Perelson, Alan S.
  • Expert Opinion on Drug Metabolism & Toxicology, Vol. 5, Issue 3
  • DOI: 10.1517/17425250902787616

Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
journal, April 2010

  • Gao, Min; Nettles, Richard E.; Belema, Makonen
  • Nature, Vol. 465, Issue 7294
  • DOI: 10.1038/nature08960

A simple cellular automaton model for influenza A viral infections
journal, January 2005

  • Beauchemin, Catherine; Samuel, John; Tuszynski, Jack
  • Journal of Theoretical Biology, Vol. 232, Issue 2
  • DOI: 10.1016/j.jtbi.2004.08.001

Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon- Therapy
journal, October 1998


Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life
journal, February 2013

  • Guedj, J.; Dahari, H.; Rong, L.
  • Proceedings of the National Academy of Sciences, Vol. 110, Issue 10
  • DOI: 10.1073/pnas.1203110110

Modeling Within-Host Dynamics of Influenza Virus Infection Including Immune Responses
journal, June 2012


Neuraminidase Inhibitor Resistance in Influenza: Assessing the Danger of Its Generation and Spread
journal, December 2007


Modeling the mechanisms of acute hepatitis B virus infection
journal, July 2007

  • Ciupe, Stanca M.; Ribeiro, Ruy M.; Nelson, Patrick W.
  • Journal of Theoretical Biology, Vol. 247, Issue 1
  • DOI: 10.1016/j.jtbi.2007.02.017

Response Prediction in Chronic Hepatitis C by Assessment of IP-10 and IL28B-Related Single Nucleotide Polymorphisms
journal, February 2011


Agent-based modeling of host–pathogen systems: The successes and challenges
journal, April 2009

  • Bauer, Amy L.; Beauchemin, Catherine A. A.; Perelson, Alan S.
  • Information Sciences, Vol. 179, Issue 10
  • DOI: 10.1016/j.ins.2008.11.012

A perspective on modelling hepatitis C virus infection: A perspective on modelling HCV infection
journal, August 2010


Modeling the interaction of cytotoxic T lymphocytes and influenza virus infected epithelial cells
journal, January 2010

  • Tridane, Abdessamad; Kuang, Yang
  • Mathematical Biosciences and Engineering, Vol. 7, Issue 1, p. 171-185
  • DOI: 10.3934/mbe.2010.7.171

Hepatitis C viral kinetics with the nucleoside polymerase inhibitor mericitabine (RG7128)
journal, February 2012

  • Guedj, Jeremie; Dahari, Harel; Shudo, Emi
  • Hepatology, Vol. 55, Issue 4
  • DOI: 10.1002/hep.24788

Viral dynamics in human immunodeficiency virus type 1 infection
journal, January 1995

  • Wei, Xiping; Ghosh, Sajal K.; Taylor, Maria E.
  • Nature, Vol. 373, Issue 6510
  • DOI: 10.1038/373117a0

Rapid host immune response and viral dynamics in herpes simplex virus-2 infection
journal, March 2013

  • Schiffer, Joshua T.; Corey, Lawrence
  • Nature Medicine, Vol. 19, Issue 3
  • DOI: 10.1038/nm.3103

Use of Laser Capture Microdissection to Map Hepatitis C Virus–Positive Hepatocytes in Human Liver
journal, December 2013


Modeling Quasispecies and Drug Resistance in Hepatitis C Patients Treated with a Protease Inhibitor
journal, May 2012

  • Rong, Libin; Ribeiro, Ruy M.; Perelson, Alan S.
  • Bulletin of Mathematical Biology, Vol. 74, Issue 8
  • DOI: 10.1007/s11538-012-9736-y

Global Transcriptome Analysis in Influenza-Infected Mouse Lungs Reveals the Kinetics of Innate and Adaptive Host Immune Responses
journal, July 2012


Mathematical Model of Antiviral Immune Response III. Influenza A Virus Infection
journal, April 1994

  • Bocharov, G. A.; Romanyukha, A. A.
  • Journal of Theoretical Biology, Vol. 167, Issue 4
  • DOI: 10.1006/jtbi.1994.1074

Rates of Spontaneous Mutation
journal, April 1998


Works referencing / citing this record:

A Robust and Efficient Numerical Method for RNA-Mediated Viral Dynamics
journal, October 2017

  • Reinharz, Vladimir; Churkin, Alexander; Dahari, Harel
  • Frontiers in Applied Mathematics and Statistics, Vol. 3
  • DOI: 10.3389/fams.2017.00020

A New Age-Structured Multiscale Model of the Hepatitis C Virus Life-Cycle During Infection and Therapy With Direct-Acting Antiviral Agents
journal, April 2018

  • Quintela, Barbara de M.; Conway, Jessica M.; Hyman, James M.
  • Frontiers in Microbiology, Vol. 9
  • DOI: 10.3389/fmicb.2018.00601

Towards a multi-level and a multi-disciplinary approach to DNA oncovirus virulence
journal, April 2019

  • Alizon, Samuel; Bravo, Ignacio G.; Farrell, Paul J.
  • Philosophical Transactions of the Royal Society B: Biological Sciences, Vol. 374, Issue 1773
  • DOI: 10.1098/rstb.2019.0041

Parameter estimation in mathematical models of viral infections using R
posted_content, April 2017

  • Nguyen, Van Kinh; Hernandez-Vargas, Esteban A.
  • bioRxiv
  • DOI: 10.1101/130674

Zika plasma viral dynamics in nonhuman primates provides insights into early infection and antiviral strategies
journal, August 2017

  • Best, Katharine; Guedj, Jeremie; Madelain, Vincent
  • Proceedings of the National Academy of Sciences, Vol. 114, Issue 33
  • DOI: 10.1073/pnas.1704011114

Special Issue “Mathematical Modeling of Viral Infections”
journal, June 2018


Mathematical Models for Immunology: Current State of the Art and Future Research Directions
journal, October 2016

  • Eftimie, Raluca; Gillard, Joseph J.; Cantrell, Doreen A.
  • Bulletin of Mathematical Biology, Vol. 78, Issue 10
  • DOI: 10.1007/s11538-016-0214-9

Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials
journal, January 2016

  • Madelain, Vincent; Nguyen, Thi Huyen Tram; Olivo, Anaelle
  • Clinical Pharmacokinetics, Vol. 55, Issue 8
  • DOI: 10.1007/s40262-015-0364-1

Towards a multi-level and a multi-disciplinary approach to DNA oncovirus virulence
journal, April 2019

  • Alizon, Samuel; Bravo, Ignacio G.; Farrell, Paul J.
  • Philosophical Transactions of the Royal Society B: Biological Sciences, Vol. 374, Issue 1773
  • DOI: 10.1098/rstb.2019.0041

Natural history, dynamics, and ecology of human papillomaviruses in genital infections of young women: protocol of the PAPCLEAR cohort study
journal, June 2019


Kinetics of Double-Stranded DNA Viremia After Allogeneic Hematopoietic Cell Transplantation
journal, September 2017

  • Hill, Joshua A.; Mayer, Bryan T.; Xie, Hu
  • Clinical Infectious Diseases, Vol. 66, Issue 3
  • DOI: 10.1093/cid/cix804

Mathematical Models for Immunology: Current State of the Art and Future Research Directions
journal, October 2016

  • Eftimie, Raluca; Gillard, Joseph J.; Cantrell, Doreen A.
  • Bulletin of Mathematical Biology, Vol. 78, Issue 10
  • DOI: 10.1007/s11538-016-0214-9

In-host modeling
journal, May 2017


Incomplete inhibition of HIV infection results in more HIV infected lymph node cells by reducing cell death
journal, March 2018


Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials
journal, January 2016

  • Madelain, Vincent; Nguyen, Thi Huyen Tram; Olivo, Anaelle
  • Clinical Pharmacokinetics, Vol. 55, Issue 8
  • DOI: 10.1007/s40262-015-0364-1

Ebola virus dynamics in mice treated with favipiravir
journal, November 2015


Towards a Multiscale Model of Acute HIV Infection
journal, January 2017


Special Issue “Mathematical Modeling of Viral Infections”
journal, June 2018


Oseltamivir PK/PD Modeling and Simulation to Evaluate Treatment Strategies against Influenza-Pneumococcus Coinfection
journal, June 2016

  • Boianelli, Alessandro; Sharma-Chawla, Niharika; Bruder, Dunja
  • Frontiers in Cellular and Infection Microbiology, Vol. 6
  • DOI: 10.3389/fcimb.2016.00060

Respiratory syncytial virus-A dynamics and the effects of lumicitabine, a nucleoside viral replication inhibitor, in experimentally infected humans
journal, October 2018

  • Patel, Kashyap; Kirkpatrick, Carl M.; Nieforth, Keith A.
  • Journal of Antimicrobial Chemotherapy, Vol. 74, Issue 2
  • DOI: 10.1093/jac/dky415

Incomplete inhibition of HIV infection results in more HIV infected lymph node cells by reducing cell death
posted_content, July 2017

  • Jackson, Laurelle; Hunter, Jessica; Cele, Sandile
  • bioRxiv
  • DOI: 10.1101/163352

Antiviral interferon response at single-cell resolution
journal, August 2018

  • Talemi, Soheil Rastgou; Höfer, Thomas
  • Immunological Reviews, Vol. 285, Issue 1
  • DOI: 10.1111/imr.12699

A theoretical framework for transitioning from patient-level to population-scale epidemiological dynamics: influenza A as a case study
journal, May 2020

  • Hart, W. S.; Maini, P. K.; Yates, C. A.
  • Journal of The Royal Society Interface, Vol. 17, Issue 166
  • DOI: 10.1098/rsif.2020.0230

Mathematical modelling identifies the role of adaptive immunity as a key controller of respiratory syncytial virus in cotton rats
journal, November 2019

  • Wethington, Darren; Harder, Olivia; Uppulury, Karthik
  • Journal of The Royal Society Interface, Vol. 16, Issue 160
  • DOI: 10.1098/rsif.2019.0389

Incomplete inhibition of HIV infection results in more HIV infected lymph node cells by reducing cell death
posted_content, July 2017

  • Jackson, Laurelle; Hunter, Jessica; Cele, Sandile
  • bioRxiv
  • DOI: 10.1101/163352

Spatiotemporal Dynamics of Virus Infection Spreading in Tissues
journal, December 2016